Table 3.
Mean post-intervention-adjusted 8-iso-PGFα and 8oxodG by treatment groups stratified by breast cancer status.
| Variable/treatment | LS Mean | LS mean CI | p value |
|---|---|---|---|
| BC history | |||
| 8-iso-PGFα (pg/mL)a | |||
| Intervention (n = 10) | 729 | 445–1197 | .37 |
| Control (n = 25) | 997 | 608–1637 | Referent |
| 8oxodG (ng/mL)a | |||
| Intervention (n = 10) | 1.1 | 1.0–1.9 | .01 |
| Control (n = 25) | 3.2 | 1.8–5.7 | Referent |
| No BC history | |||
| 8-iso-PGFα (pg/mL)a | |||
| Intervention (n = 10) | 670 | 478–966 | .67 |
| Control (n = 24) | 755 | 536–1064 | Referent |
| 8oxodG (ng/mL)a | |||
| Intervention (n = 10) | 2.5 | 1.7–3.7 | .81 |
| Control (n = 24) | 2.6 | 1.8–4.0 | Referent |
a
From analysis using log values, mean values were back-transformed for presentation.
Adjustments: 8-iso-PGFα = baseline 8-iso-PGFα, age, and body mass index; 8oxodG = baseline 8oxodG and education status.